Stock News
Unlocking the Potential: Relay Therapeutics’ RLY-2608 Data Paves the Way for Program Expansion
Exciting Developments in Breast Cancer Treatment Relay Therapeutics, Inc. recently shared positive interim data from its phase 1 ReDiscover study, which focused on the use of RLY-2608 in combination with fulvestrant to treat PI3Ka-mutated HR+/HER2- locally advanced or metastatic breast cancer patients. This news marks a significant step forward in the fight against this deadly…
ROSEN Top-Ranked Investor Counsel Urges Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action (AGEN)
Rosen Law Firm Announces Class Action Lawsuit Against Agenus Inc. New York, Sept. 16, 2024 (GLOBE NEWSWIRE) Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023 and July 17, 2024, both dates…
Breaking News: Local Bank Gives Thumbs Up to $55 Million Share Buyback Plan!
Welcome to the F&M Bank Blog! Exciting News from Farmers & Merchants Bancorp Hey there, fellow money-savvy folks! Have you heard the latest news from Farmers & Merchants Bancorp? Well, hold onto your hats because they have just announced some major changes that are shaking up the financial world! So here’s the scoop: Farmers &…
From IPO to Shareholder Success: DSS Inc. Cheers on Impact BioMedical Inc.’s Big Win!
Exciting News in the Biomedical Industry! NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful pricing of Impact BioMedical’s initial public offering (IPO). Impact BioMedical, a trailblazer in advancing human healthcare and wellness…
Big News Alert: MBX Biosciences Goes Public and We’re Here for It!
Breaking News: MBX Biosciences Announces Successful IPO What does this mean for the world of biopharmaceuticals? Well folks, it looks like MBX Biosciences is making waves in the world of precision peptide therapies for endocrine and metabolic disorders. With their recent upsized initial public offering, it seems like they are set to make a big…
Unlocking the Power of Accesswire: A Must-Read Article for Bloggers and Readers
TechPrecision Corporation Reports Backlog Increased to $50 Million Customer Confidence Remains High as Fourth Quarter and Fiscal Year Results Released WESTMINSTER, MA / ACCESSWIRE / September 16, 2024 TechPrecision Corporation, a leading manufacturer of precision metal components and systems for the defense and precision industrial sectors, announced today that its backlog has increased to $50…
I-Mab Shares Exciting Phase 1 Givastomig Data at ESMO 2024
Welcome to the Future of Cancer Treatment! Promising Results for Givastomig in Gastric Cancer Patients Have you heard the news? I-Mab, a global biotech company, has just released exciting findings from their Phase 1 clinical study of givastomig, a groundbreaking immunotherapy drug. This study focused on patients with advanced cancers, with a special emphasis on…
Midnight Sun Confirms Kazhiba Licence Remains in Good Standing
Welcome to the Future of Mining Exploration with Midnight Sun Mining Corporation Clarification on Large Scale Exploration Licence Renewal Vancouver, British Columbia–(Newsfile Corp. – September 16, 2024) – Midnight Sun Mining Corporation (TSXV: MMA) (OTC Pink: MDNGF) (“Midnight Sun” or the “Company”) announces that, further to its August 29, 2024 news release, the renewal application…